Quality Control
Functionality tested in Real-time PCR for specificity, sensitivity and reproducibility for each primer sets using different cell lines, Breast cancer samples and Colon cancer tissues.
Targeted Therapy Assay Service
NanoCinna Pharmacogenomics Center
Targeted therapy
The limitations of chemotherapy, radiotherapy, and surgery are apparent and have been the impetus for developing targeted therapies. Targeted therapy is a type of medication that blocks the growth of cancer cells by interfering with specific targeted molecules needed for carcinogenesis and tumor growth, rather than by simply interfering with rapidly dividing cells (e.g. with traditional chemotherapy). Targeted drugs are active as single agents for the treatment of cancer and offer the opportunity to reverse resistance to chemotherapy and hormonal therapy. Targeted therapies have been established for the treatment of advanced cancers and are now demonstrating benefit in the adjuvant arena. The main categories of targeted therapy are small molecules and monoclonal antibodies. Listed below are a number of targets for these drugs:
Application
Evaluation of Radiotherapy sensitivity
Sampling Condition
Fresh or snap-frozen tumor and its tumor
borderline are needed, for more information
please contact us
Catalog Number
#S1377 Targeted therapy assay
#S1378 Her2, EpCAM and EGFR assay
#S1379 C-kit and PDGFR assay
#S1380 SRC assay
#S1381 FLT3 assay
#S1382 EML4-ALK assay
#S1383 VEGF and VEGFR assay
#S1377 description
NanoCinna evaluates the Targeted therapy for solid tumor with expression analysis of 10 genes:
1- Her2/neu
2- EGFR
3- VEGF
4- FLT3
5- PDGFR
6- SRC
7- EML4-ALK
8- C-kit
9- VEGFR2
10- EpCAM
